Desktop Navigation Loading...
Mobile Navigation Loading...
Mobile Search Loading...
Desktop Search Loading...

CEPI Updates & Insights

Sign up to our monthly newsletter for the latest developments in the fight to end pandemics. Packed with announcements, editorial content, funding opportunities and more – our monthly newsletter covers it all.

Subscribe via LinkedIn
A team on researchers working in a modern laboratory, one researcher is on a computer looking at virus cells, another researcher is looking through a microscope

To receive it directly to your inbox, subscribe below.

Subscribe via email

Where to go next

NewsRead moreStoriesRead moreMedia resourcesRead more
CEPI

About

  • Our approach

  • CEPI 2.0 and the 100 Days Mission
  • Equitable access
  • The CEPI team

  • Board members & committees
  • Investors
  • Joint Coordination Group
  • Scientific Advisory Committee
  • Portfolio Strategy & Management Board
  • Why we exist

  • Documents library

  • Careers

What we do

  • Research & development

  • Enabling science
  • Vaccine technology
  • Artificial Intelligence
  • Biosecurity
  • CEPI Technical Resources Hub
  • Process development and manufacturing

  • Priority pathogens

  • Chikungunya
  • Coronaviruses
  • Disease X
  • Filoviruses
  • Lassa fever
  • Mpox
  • Nipah
  • Rift Valley fever
  • Our portfolio

  • Policy briefing room

Partner with us

  • Support CEPI

  • Calls for proposals

  • Procurement tenders

  • Our coalition

Our impact

  • Impact in focus

  • Progress and results

News & stories

  • News

  • Stories

  • How climate change increases pandemic risk
  • The Viral Most Wanted
  • Media resources

  • Events

  • Global Pandemic Preparedness Summit 2024

Legal

  • Child Protection Statement

  • Cookie Policy

  • External Privacy Notice

  • Modern Slavery, Human Trafficking and Human Rights Statement

  • Navigating CEPI's Third Party Code

  • Reporting concern

  • Tackling Racism

Social

  • Bluesky

  • Facebook

  • Linkedin

  • X

©2025 CEPI. All rights reserved